1Departments of Neurology and Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida , Gainesville, FL , USA.
Int J Neurosci. 2013 Dec;123(12):847-9. doi: 10.3109/00207454.2013.810626. Epub 2013 Jul 9.
Parkin mutations are a common cause of early-onset Parkinson's disease. To study the clinical features and treatment responses of patients with homozygous or heterozygous Parkin mutations, we performed a retrospective chart review in six early-onset parkinsonism patients with pathogenic Parkin mutations. The clinical phenotypes observed in this cohort, all drawn from different families, were variable. All patients had a slowly progressive form of parkinsonism that responded well to dopaminergic therapy with the exception of one advanced case. Homozygous patients had an earlier age at disease onset than heterozygous patients. Two of our patients underwent bilateral deep brain stimulation (DBS) of the subthalamic nucleus or globus pallidus leading to a sustained positive response. Our observations support an earlier age of onset for homozygous cases and possible beneficial effects of DBS in Parkin-related parkinsonism.
Parkin 突变是早发性帕金森病的常见病因。为了研究纯合或杂合 Parkin 突变患者的临床特征和治疗反应,我们对 6 名具有致病性 Parkin 突变的早发性帕金森病患者进行了回顾性图表审查。该队列观察到的临床表型来自不同的家族,各不相同。所有患者均表现为缓慢进展型帕金森病,对多巴胺能治疗反应良好,除了一个晚期病例。纯合子患者的发病年龄早于杂合子患者。我们的两名患者接受了丘脑底核或苍白球双侧深部脑刺激 (DBS),导致持续的积极反应。我们的观察结果支持纯合子病例发病年龄更早,以及 DBS 在 Parkin 相关帕金森病中的可能有益作用。